Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal
IIPRD
APRIL 2, 2024
Branded drugs are typically controlled by one manufacturer with exclusivity, while the generic industry operates with multiple competitors, resulting in a decline in generic drug prices since 2008 while branded drug prices continue to rise. [ix] xiii] Ensuring access to affordable medications is a key priority for India.
Let's personalize your content